You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 065364

✉ Email this page to a colleague

« Back to Dashboard

NDA 065364 describes COLISTIMETHATE SODIUM, which is a drug marketed by Avet Lifesciences, Fresenius Kabi Usa, Nexus, Pharmobedient, Sagent Pharms Inc, and Xellia Pharms Aps, and is included in six NDAs. It is available from three suppliers. Additional details are available on the COLISTIMETHATE SODIUM profile page.

The generic ingredient in COLISTIMETHATE SODIUM is colistimethate sodium. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the colistimethate sodium profile page.

Summary for 065364

Tradename:	COLISTIMETHATE SODIUM
Applicant:	Fresenius Kabi Usa
Ingredient:	colistimethate sodium
Patents:	0

Pharmacology for NDA: 065364

Suppliers and Packaging for NDA: 065364

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
COLISTIMETHATE SODIUM	colistimethate sodium	INJECTABLE;INJECTION	065364	ANDA	Fresenius Kabi USA, LLC	63323-393	63323-393-06	1 VIAL in 1 BOX (63323-393-06) / 2 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	EQ 150MG BASE/VIAL
Approval Date:	Apr 17, 2008	TE:	AP	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.